INTERNATIONAL PATENT: ATHIRA PHARMA, INC. FILES APPLICATION FOR "MODULATORS OF PANNEXIN-1 ACTIVITY"

GENEVA, March 25 -- ATHIRA PHARMA, INC. (18706 North Creek ParkwaySuite 104Bothell, Washington 98011) filed a patent application (PCT/US2025/046327) for "MODULATORS OF PANNEXIN-1 ACTIVITY" on Sep 15, 2025. With publication no. WO/2026/060341, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TSO, Kin (c/o Athira Pharma, Inc.18706 North Creek Parkway, Suite 104Bothell, Washington 98011), BOATMAN, Douglas (c/o Athira Pharma, Inc.18706 North Creek Parkway, Suite 104Bothell, Washington 98011), SARATHY, Apurva (c/o Athira Pharma...